Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Adoptive t-cell therapy using FcεRI-based chimeric antigen receptors for treating IgE-mediated allergic diseases

Adoptive t-cell therapy using FcεRI-based chimeric antigen receptors for treating IgE-mediated allergic diseases

US Patent 10195272 · Granted Feb 5, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adoptive T-cell therapy using EMPD-specific chimeric antigen receptors for treat2022
Device for generating and delivering low temperature plasma2020